Prognostic factors in older AML patients receiving intensive and non-intensive therapy: analysis of the UK AML 11 and AML 14 trials

Research output: Contribution to journal › Abstract

Cite this

@article{e987ba7fbdff46d78a720fa4ed936035,

title = "Prognostic factors in older AML patients receiving intensive and non-intensive therapy: analysis of the UK AML 11 and AML 14 trials",

author = "Keith Wheatley and Cassandra Brookes and Robert Hills and AH Goldstone and Donald Milligan and AG Prentice and AV Moorman and AK Burnett",

year = "2005",

month = jan,

day = "1",

language = "English",

volume = "106",

pages = "199a",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

}

TY - JOUR

T1 - Prognostic factors in older AML patients receiving intensive and non-intensive therapy: analysis of the UK AML 11 and AML 14 trials

AU - Wheatley, Keith

AU - Brookes, Cassandra

AU - Hills, Robert

AU - Goldstone, AH

AU - Milligan, Donald

AU - Prentice, AG

AU - Moorman, AV

AU - Burnett, AK

PY - 2005/1/1

Y1 - 2005/1/1

M3 - Abstract

SN - 1528-0020

VL - 106

SP - 199a

JO - Blood

JF - Blood

IS - 11

ER -